

Cover Story
COVID-19 & CancerFree
By Alexandria Carolan
Forecasts of the inevitable spread of coronavirus can be difficult to ignore, especially at a time when many of us are making travel plans for this spring’s big cancer meetings.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for March 2020
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research